•  
  •  
  •  
  •  

2023-06-03 07:23:47

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Asahi SongwonColors Limited reports Q4FY23 Results
  • Lemon Tree Hotels launches two new hotels - one each in Agra and Bhopal
  • Hero MotoCorp launches new range of 100cc motorcycle - the HF Deluxe
  • USFDA inspection at Zydus' animal health drug manufacturing facility at SEZ, Ahmedabad
  • Cravatex Limited releases mortgage on properties

Keywords Selected:  TentativeApproval

Stock Report

  • Laurus Labs receives USFDA tentative approval for the World's First Paediatric ARV Oral Dispersible Film drug, Dolutegravir 5mg and 10mg in HIV/AIDS treatment
  • Lupin receives tentative approval from U.S. FDA for Valbenazine Capsules
  • Lupin receives tentative approval from U.S. FDA for Obeticholic Acid Tablets
  • Alembic Pharmaceuticals announces USFDA Tentative Approval for Brexpiprazole Tablets
  • Zydus receives tentative approval from the USFDA for Gabapentin Tablets, 300 mg and 600 mg
  • Glenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mg
  • Zydus receives tentative approval from the USFDA for Canagliflozin Tablets
  • Zydus receives tentative approval from the USFDA for Bosentan Tablets for Oral Suspension
  • Lupin receives Tentative Approval from U.S. FDA for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets
  • Alembic Pharmaceuticals receives USFDA Tentative Approval for Acalabrutinib Capsules, 100 mg
  • Lupin receives Tentative Approval from U.S. FDA for Dolutegravir and Rilpivirine Tablets
  • Zydus receives tentative approval from the USFDA for Levomilnacipran Extended-Release Capsules
  • Zydus receives tentative approval from the USFDA for Levothyroxine Sodium for Injection
  • Lupin receives Tentative Approval from U.S. FDA for Doxycycline Capsules
  • Lupin receives Tentative Approval from U.S. FDA for Drospirenone Tablets
  • Zydus receives tentative approval from the USFDA for Roflumilast Tablets
  • Zydus receives tentative approval from the USFDA for Valbenazine Capsules
  • Zydus receives tentative approval from the USFDA for Amantadine Extended-Release Capsules
  • Shilpa Medicare Ltd receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
  • Zydus receives tentative approval from the USFDA for Sugammadex Injection
  • Lupin receives tentative approval from U.S. FDA for Dasatinib Tablets
  • NATCO announces tentative approval to its ANDA for Trabectedin
  • Alembic Pharmaceuticals receives USFDA Tentative Approval for Dasatinib Tablets
  • Lupin receives tentative approval from U.S. FDA for Ivacaftor Tablets

Latest Post

  • Asahi SongwonColors Limited reports Q4FY23 Results
  • Lemon Tree Hotels launches two new hotels - one each in Agra and Bhopal
  • Hero MotoCorp launches new range of 100cc motorcycle - the HF Deluxe
  • USFDA inspection at Zydus' animal health drug manufacturing facility at SEZ, Ahmedabad
  • Cravatex Limited releases mortgage on properties


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022